NCT01047761

Brief Summary

Generalized fatigue in myasthenia gravis results in physical deconditioning that reduces fitness and increases risk of obesity, hypertension, elevated cholesterol and type 2 diabetes. This study will examine how active and fit are 30 individuals with chronic, generalized myasthenic subjects. This study will also determine whether a 3 month home exercise program with aerobic, resistive, and pulmonary training can improve physical activity, strength, fitness, lung function and reduce cardiovascular disease risk.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Jan 2010

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 13, 2010

Completed
10.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

November 1, 2016

Status Verified

October 1, 2016

Enrollment Period

10.9 years

First QC Date

January 12, 2010

Last Update Submit

October 28, 2016

Conditions

Keywords

Myasthenia GravisExerciseFitnessBody CompositionPhysical ActivityPulmonary FunctionBalance

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular Fitness, Economy of Gait, Physiologic Reserve

    Baseline and 3 months

Secondary Outcomes (7)

  • Ambulatory function (6 minute walk, 5 day step activity and accelerometer data)

    Baseline and 3 month

  • Muscle strength by dynamometer

    Baseline and 3 month

  • Myasthenia Quality of Life Scale, SF-36, and Visual Analogue Fatigue Scale

    Baseline and 3 months

  • Cardiovascular risk profile (fasting glucose, oral glucose tolerance test, HbA1c, lipids), smoking status, and body mass index

    Baseline and 3 months

  • Body Composition by DEXA and CT of mid-thigh and hip

    Baseline and 3 months

  • +2 more secondary outcomes

Study Arms (1)

exercise

EXPERIMENTAL

Multimodal exercises that include walking, breathing exercises, dynamic balance, and core strengthening.

Other: Exercise

Interventions

3 month exercise intervention, three days a week Progressive in duration - up to 1 hour daily; Progressive in intensity Multi-modal exercise program includes a) aerobic - walking, b) resistive training with therabands and core exercises, and c) breathing exercises

exercise

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • stable generalized myasthenia gravis
  • adults age 18-70

You may not qualify if:

  • already performing regular exercise
  • unstable angina
  • recent (\<3 month) myocardial infarction, stroke, hospitalization for major illness or major surgery
  • chronic pain or orthopedic condition restricting exercise
  • active cancer, excluding basal cell cancer
  • anemia (HCT \<30)
  • pregnancy
  • myasthenia gravis exacerbation in past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland and Baltimore VA Medical Center

Baltimore, Maryland, 21201, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Myasthenia GravisMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Paraneoplastic Syndromes, Nervous SystemNervous System NeoplasmsNeoplasms by SiteNeoplasmsParaneoplastic SyndromesAutoimmune Diseases of the Nervous SystemNervous System DiseasesNeurodegenerative DiseasesNeuromuscular Junction DiseasesNeuromuscular DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Charlene E Hafer-Macko, MD

    Baltimore VA Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Charlene Hafer-Macko, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Myasthenia Gravis and Exercise

Study Record Dates

First Submitted

January 12, 2010

First Posted

January 13, 2010

Study Start

January 1, 2010

Primary Completion

December 1, 2020

Study Completion

December 1, 2020

Last Updated

November 1, 2016

Record last verified: 2016-10

Locations